Compound ID | 2115
Class: Natural product antibiotic
| Spectrum of activity: | Gram-negative |
| Details of activity: | Inhibits fatty acid synthesis by binding to FabH, FabB and FabF. Activity against E. coli, Bacteroides fragilis |
| Description: | Natural product produced by Streptomyces total synthesis; several analogues |
| Year first mentioned: | 1983 |
| Development status: | Experimental |
| Reason Dropped: | Enhances ATPase activity of myosin B from skeletal muscle |
| Chemical structure(s): | |||||||||||
|
|